Evidence map›Paper›PMID 21085672›Full record

ArticlePloS one2010

Induction of glucose metabolism in stimulated T lymphocytes is regulated by mitogen-activated protein kinase signaling.

Aimee J Marko, Rebecca A Miller, Alina Kelman, Kenneth A Frauwirth

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Research advances in the role of MAPK cascade in regulation of cell growth, immunity, inflammation, and cancer.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aimee J MarkoDepartment of Cell Biology and Molecular Genetics and Maryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America.
Rebecca A Miller
Alina Kelman
Kenneth A Frauwirth
University of Maryland, College Park · US

Funding

Signaling Pathways for Anergy Induction and MaintenanceK01CA092156 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI FRAUWIRTH, KENNETH A · 2003 to 2007
$741k
NCI NIH HHS K01 CA092156
6 · The paper itself

Abstract

T lymphocytes play a critical role in cell-mediated immune responses. During activation, extracellular and intracellular signals alter T cell metabolism in order to meet the energetic and biosynthetic needs of a proliferating, active cell, but control of these phenomena is not well defined. Previous studies have demonstrated that signaling from the costimulatory receptor CD28 enhances glucose utilization via the phosphatidylinositol-3-kinase (PI3K) pathway. However, since CD28 ligation alone does not induce glucose metabolism in resting T cells, contributions from T cell receptor-initiated signaling pathways must also be important. We therefore investigated the role of mitogen-activated protein kinase (MAPK) signaling in the regulation of mouse T cell glucose metabolism. T cell stimulation strongly induces glucose uptake and glycolysis, both of which are severely impaired by inhibition of extracellular signal-regulated kinase (ERK), whereas p38 inhibition had a much smaller effect. Activation also induced hexokinase activity and expression in T cells, and both were similarly dependent on ERK signaling. Thus, the ERK signaling pathway cooperates with PI3K to induce glucose utilization in activated T cells, with hexokinase serving as a potential point for coordinated regulation.

Indexed as

AnimalsAntibodies, MonoclonalButadienesCD28 AntigensCD3 ComplexCell Line, TumorCells, CulturedEnzyme AssaysEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesGlucoseGlycolysisHexokinaseImidazolesLymphocyte ActivationMAP Kinase Signaling SystemAntibodies, MonoclonalButadienesCD28 AntigensCD3 ComplexEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesGlucoseHexokinaseImidazolesNitrilesp38 Mitogen-Activated Protein KinasesPyridinesSB 203580U 0126

Identifiers

PMID21085672
PMCPMC2978105
OpenAlexW2060252101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.